New two-year findings from the Phase 2/3 long-term extension demonstrate sustained disease control through two years, ...

Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today ...

So far this year in the United States, there have been, that we know of, 3,659 measles cases — nearly 1,400 more than there were last year, so it’s definitely a great time to hold a summit all about ...

Median interval between end of initial treatment course and first retreatment infusion was 16.6 months No new safety signals reported; safety profile consistent with previously reported data Topline ...

Collagen has been at the forefront of many ingredient lists and marketing campaigns within the skincare industry lately. It ...

Welcome to Palatin's Fourth Quarter and Fiscal Year-End 2026 Operating Results Conference Call. [Operator Instructions] As a ...

Martha Rosenberg is an award-winning investigative public health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks ...

(Adnkronos) - "I felt unwell due to an edema caused by a tumor. They operated on me and removed almost all of the tumor. Now I have to follow the therapies." Alessandro Di Battista, on diMartedì, ...